Cited by 70Stress Responses and CortisolTreatment of Major DepressionAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes

Dex/CRH test cortisol response in outpatients with major depression and matched healthy controls

Open access
Carpenter, Linda L., Ross, Nicole S., Tyrka, Audrey R., Anderson, George M., Kelly, Megan, Price, Lawrence H.·2009·Psychoneuroendocrinology

Abstract

Background The dexamethasone/corticotropin releasing hormone (Dex/CRH) test has been proposed as a potential tool for identifying endophenotypes relevant to mood disorders. An exaggerated cortisol response to the test during major depressive episodes has been demonstrated for inpatients with melancholic or psychotic features. A diminished hormone response has been observed in chronically depressed outpatients.Methods Following a battery of self-report and interview assessments, 68 adults completed the Dex/CRH test. Thirty-four met structured interview criteria for current major depressive disorder and 34 age- and sex-matched control subjects had no current or lifetime DSM-IV depressive disorder. Effect of diagnosis on cortisol response to the Dex/CRH test was examined in a repeated measures general linear model.Results The matched groups were equivalent with regard to childhood adversity. Cortisol response to the Dex/CRH test among subjects with current MDD was not significantly different from that seen in matched healthy controls. Independent of diagnosis, an exploratory analysis showed a trend-level association between maltreatment history and diminished cortisol response; no interactive effects with depression diagnosis were detected.Conclusions The results do not support the hypothesis that elevated cortisol response to the Dex/CRH test represents a marker for major depressive episodes.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.psyneuen.2009.03.009

Cites

33 of 33 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The DST achieved only a modest sensitivity between 20 and 50% to detect MDD.

    “However, the DST achieved only a modest sensitivity between 20 and 50% to detect MDD [52, 53]”

    From The HPA Axis as Target for Depression (2024) · cites this paper as [53]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. First MB Spitzer RL Structured Clinical Interview for DSM-IV Axis I Disorders, Patient Edition (SCID-I/P) 1996 New York State Psychiatric Institute, Biometrics Research New York, NY

Cited by

Sorted by citations

Authors
Carpenter, L. L., Ross, N. S., Tyrka, A. R., Anderson, G. M., Kelly, M., & Price, L. H.
Affiliations
  • Brown University (US)
  • Yale University (US)
Corresponding author
Carpenter, Linda L.
Venue
Psychoneuroendocrinology
Publisher
Elsevier BV
Published
2009-09
Volume
34
Issue
8
Pages
1208-1213
ISSN
0306-4530 (ISSN-L)
OpenAlex
W1990912500
Cited by
70
References
33
Citations by year
2025: 1 · 2024: 1 · 2023: 5 · 2022: 4 · 2021: 1 · 2020: 4 · 2019: 3 · 2018: 4 · 2017: 4 · 2016: 6 · 2015: 7 · 2014: 6 · 2013: 9 · 2012: 2
FWCI
1.90
Type
journal article
Language
en
Open access
Locations
  • Psychoneuroendocrinology (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • U.S. Department of the Interior
  • Medtronic
  • National Institutes of Health
  • U.S. Department of Defense
Topics
  • Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
  • Health Sciences › Medicine › Pharmacology › Treatment of Major Depression
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
Keywords
dexamethasone/corticotropin-releasing hormone test, cortisol response, major depressive disorder, endophenotypes, child abuse, childhood adversity, hypothalamic-pituitary-adrenal axis, outpatients, depression biomarkers
MeSH terms
Adult, Child, Child Abuse, Corticotropin-Releasing Hormone, Major Depressive Disorder, Dexamethasone, Female, Humans, Hydrocortisone, Hypothalamo-Hypophyseal System, Male, Middle Aged, Pituitary-Adrenal System, Case-Control Studies

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review